Charles Vogel

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

Journal of Clinical Oncology · 2002 · First of 13 authors · 2,488 citations

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after…

Journal of Clinical Oncology · 1999 · 2,255 citations